Gemcitabine (1gm)
Gemlife RD 1000 mg Injection is used in the treatment of non-small cell lung cancer, breast cancer, pancreatic cancer, urinary bladder cancer and ovarian cancer.
1 Injection in 1 vial
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Gemlife RD 1000 mg Injection interferes with the growth of DNA and RNA of the cancer cells by substituting their building blocks. It prevents the cancer cells from growing and multiplying.
Related Warnings
Interaction with alcohol is unknown. Please consult your doctor.
Gemlife RD 1000 mg Injection is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Gemlife RD 1000 mg Injection is unsafe to use during lactation. Data suggests that the drug may cause toxicity to the baby, or the mother is suffering from a condition in which breastfeeding is not advisable.
Gemlife RD 1000 mg Injection may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
There is limited information available on the use of Gemlife RD 1000 mg Injection in patients with kidney disease. Please consult your doctor.
Kidney function tests are advised before taking this medicine and regular monitoring is also recommended after the treatment.
There is limited information available on the use of Gemlife RD 1000 mg Injection in patients with liver disease. Please consult your doctor.
